Live: Will Webull Crush Q2 Earnings Tonight After Rising 7.5% Today?

Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

736 Articles

Trey Thoelcke | Feb 26, 2016 at 11:56 AM EST

Big Pharma Matchup: Valeant vs Gilead

Here are two big biopharmas, both with multibillion dollar portfolios and both of which have lost a combined $113 billion…

Jon C. Ogg | Feb 25, 2016 at 5:15 PM EST

Why Citi Sees Huge Upside in 4 Top Biotechs Now

Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four…

Chris Lange | Feb 25, 2016 at 8:46 AM EST

Short Interest Rises Across the Board in Major Biotechs

The February 12 short interest data have been compared with the previous report, and short interest increased across the board…

Jon C. Ogg | Feb 25, 2016 at 7:25 AM EST

The 18 Companies That Will Buy Back the Most Stock in 2016

It is time to take a look at the 2016 stock buyback kings, those companies that will spend the most…

Jon C. Ogg | Feb 14, 2016 at 9:32 AM EST

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside…

Jon C. Ogg | Feb 12, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Activision Blizzard, Boeing, FireEye, Gilead, Groupon, Netflix, Pandora and More

The top analyst upgrades, downgrades and initiations seen on Friday include Activision Blizzard, Boeing, FireEye, Gilead Sciences, Groupon, Netflix and…

Chris Lange | Feb 10, 2016 at 8:40 AM EST

Major Biotech Short Interest Continues to Be Mixed

The January 29 short interest data have been compared with the previous report, and short interest was mixed in most…

Chris Lange | Feb 6, 2016 at 10:50 AM EST

How Analysts Value Gilead Now After Earnings

After Gilead Sciences reported fourth-quarter financial results on Tuesday, analysts weighed in on this biotech giant and in what direction…

Chris Lange | Feb 2, 2016 at 4:31 PM EST

Gilead Rises on Solid HCV Sales and Earnings Beat

Gilead Sciences reported better-than-expected fourth-quarter financial results after the markets closed on Tuesday.

Paul Ausick | Feb 2, 2016 at 4:04 PM EST

Tesla Hits 52-Week Low

February 2, 2016: Here are five stocks trading with heavy volume among 209 equities making new 52-week lows today. Tesla Motors…

Chris Lange | Feb 2, 2016 at 12:55 PM EST

What Expect From Gilead Earnings

Gilead Sciences is set to release its fourth-quarter earnings report after the markets close on Tuesday.

Paul Ausick | Feb 1, 2016 at 4:04 PM EST

The 52-Week Low Club for Monday

February 1, 2016: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows today. Gilead…

Lee Jackson | Feb 1, 2016 at 9:50 AM EST

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the…

Paul Ausick | Jan 29, 2016 at 4:04 PM EST

The 52-Week Low Club for Friday

January 29, 2016: Here are four stocks trading with heavy volume among 119 equities making new 52-week lows today. Gilead…

Chris Lange | Jan 28, 2016 at 8:35 AM EST

Short Sellers Increase Bets in Major Biotechs

Short interest increased in most of these selected biotech stocks for the most recent settlement date.

1 … 27 28 29 30 31 … 50

Gilead Sciences : GILD

All Gilead Sciences Articles

Big Pharma Matchup: Valeant vs Gilead

Why Citi Sees Huge Upside in 4 Top Biotechs Now

Short Interest Rises Across the Board in Major Biotechs

The 18 Companies That Will Buy Back the Most Stock in 2016

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

Top Analyst Upgrades and Downgrades: Activision Blizzard, Boeing, FireEye, Gilead, Groupon, Netflix, Pandora and More

Major Biotech Short Interest Continues to Be Mixed

How Analysts Value Gilead Now After Earnings

Gilead Rises on Solid HCV Sales and Earnings Beat

Tesla Hits 52-Week Low

What Expect From Gilead Earnings

The 52-Week Low Club for Monday

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

The 52-Week Low Club for Friday

Short Sellers Increase Bets in Major Biotechs

Live: Will Webull Crush Q2 Earnings Tonight After Rising 7.5% Today?

Cramer Warns Fintech Bulls: These Three Stocks Are Priced for Perfection

Which Big Bank Stock Has Dominated in 2026: Bank of America, Wells Fargo, or Bank of New York Mellon Corp.?

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

At 88, He Still Climbs Ladders at His Shoe Store. His Age Ended the Earnings Test, but Not the Social Security Tax.

Housing Starts Plunge 10% as Mortgage Rates Climb to 6.75%, Builders Brace for Demand Collapse

Cramer Warns Fintech Bulls: These Three Stocks Are Priced for Perfection

Which Big Bank Stock Has Dominated in 2026: Bank of America, Wells Fargo, or Bank of New York Mellon Corp.?

Gilead Sciences : GILD

All Gilead Sciences Articles

Big Pharma Matchup: Valeant vs Gilead

Why Citi Sees Huge Upside in 4 Top Biotechs Now

Short Interest Rises Across the Board in Major Biotechs

The 18 Companies That Will Buy Back the Most Stock in 2016

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

Top Analyst Upgrades and Downgrades: Activision Blizzard, Boeing, FireEye, Gilead, Groupon, Netflix, Pandora and More

Major Biotech Short Interest Continues to Be Mixed

How Analysts Value Gilead Now After Earnings

Gilead Rises on Solid HCV Sales and Earnings Beat

Tesla Hits 52-Week Low

What Expect From Gilead Earnings

The 52-Week Low Club for Monday

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

The 52-Week Low Club for Friday

Short Sellers Increase Bets in Major Biotechs

Live: Will Webull Crush Q2 Earnings Tonight After Rising 7.5% Today?

Cramer Warns Fintech Bulls: These Three Stocks Are Priced for Perfection

Which Big Bank Stock Has Dominated in 2026: Bank of America, Wells Fargo, or Bank of New York Mellon Corp.?

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

Featured Reads

At 88, He Still Climbs Ladders at His Shoe Store. His Age Ended the Earnings Test, but Not the Social Security Tax.

Housing Starts Plunge 10% as Mortgage Rates Climb to 6.75%, Builders Brace for Demand Collapse